NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

This is exactly why whenever I am advised by company surrogates to talk to David Innes, I decline. He may not tell me anything that is not already in the public and does not have to stand behind anything he says in private even if he is not speaking to something material.

For example I am not sure that the fact that NWBO would or would not PR an application to a regulator is material. I think a real confirmation that they would PR an application should impact the share price, in part because it would tell us that we have much longer to wait as no application has even been filed.

Similarly, if NWBO confirmed only approval would be PR’d then that should impact the share price as it already being June 2023, and given that most shareholders cling to optimism they would think that this mean we have surely filed by now and must be waiting on approval which could come any day.

As always, NWBO refuses to share even basic information they legally can and it is shareholders left holding the bag.